Airsculpt Technologies, Inc. ( (AIRS) ) has released its Q1 earnings. Here is a breakdown of the information Airsculpt Technologies, Inc. presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AirSculpt Technologies, Inc. is a national provider of premium body contouring procedures, specializing in minimally invasive treatments that enhance comfort and precision in the healthcare sector. The company recently released its first quarter fiscal 2025 results, showing a decline in revenue and case volume compared to the previous year. Despite a 17.3% drop in revenue to $39.4 million and a net loss of $2.8 million, the company has implemented cost reduction initiatives that have improved profitability compared to the previous quarter. AirSculpt’s CEO, Yogi Jashnani, expressed confidence in the company’s strategic direction, highlighting efforts to enhance marketing and sales strategies, as well as the introduction of new financing options and a pilot for standalone skin tightening services. Looking ahead, AirSculpt projects full-year revenues between $160 to $170 million and adjusted EBITDA of $16 to $18 million, focusing on long-term growth and shareholder value.